| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort. | J Antimicrob Chemother | 2010 | 1.28 |
| 2 | Phase II dose escalation study of caspofungin for invasive Aspergillosis. | Antimicrob Agents Chemother | 2011 | 0.87 |
| 3 | Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome. | Eur J Clin Pharmacol | 2012 | 0.79 |
| 4 | [Posaconazole: another triazole antifungal of the new generation?]. | Dtsch Med Wochenschr | 2008 | 0.75 |